This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marlowe, E. M.
Right arrow Articles by Bruckner, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marlowe, E. M.
Right arrow Articles by Bruckner, D. A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, July 2001, p. 2637-2639, Vol. 39, No. 7
0095-1137/01/$04.00+0   DOI: 10.1128/JCM.39.7.2637-2639.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Practical Strategies for Detecting and Confirming Vancomycin-Intermediate Staphylococcus aureus: a Tertiary-Care Hospital Laboratory's Experience

Elizabeth M. Marlowe,* Martin D. Cohen, Janet F. Hindler, Kevin W. Ward, and David A. Bruckner

Department of Pathology and Laboratory Medicine, University of California Los Angeles Medical Center, Los Angeles, California

Received 21 February 2001/Returned for modification 31 March 2001/Accepted 15 April 2001

The clinical microbiology laboratory plays a critical role in the detection of Staphylococcus aureus with decreased susceptibility to vancomycin. Staff education and rapid laboratory response are of utmost importance. We report on our laboratory's experience and provide recommendations for the identification and confirmation of vancomycin-intermediate S. aureus.

* Corresponding author. Mailing address: Department of Pathology and Laboratory Medicine, Medical Center, University of California, Los Angeles, 10833 Le Conte Ave., Los Angeles, CA 90095-1713. Phone: (310) 794-2766. Fax: (310) 794-2765. E-mail: bmarlowe{at}ucla.edu.

Journal of Clinical Microbiology, July 2001, p. 2637-2639, Vol. 39, No. 7
0095-1137/01/$04.00+0   DOI: 10.1128/JCM.39.7.2637-2639.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Wang, G., Hindler, J. F., Ward, K. W., Bruckner, D. A. (2006). Increased Vancomycin MICs for Staphylococcus aureus Clinical Isolates from a University Hospital during a 5-Year Period. J. Clin. Microbiol. 44: 3883-3886 [Abstract] [Full Text]  
  • Brown, D. F. J., Edwards, D. I., Hawkey, P. M., Morrison, D., Ridgway, G. L., Towner, K. J., Wren, M. W. D., on behalf of the Joint Working Party of the Britis, (2005). Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA). J Antimicrob Chemother 56: 1000-1018 [Abstract] [Full Text]  
  • Kim, M.-N., Hwang, S. H., Pyo, Y.-J., Mun, H.-M., Pai, C. H. (2002). Clonal Spread of Staphylococcus aureus Heterogeneously Resistant to Vancomycin in a University Hospital in Korea. J. Clin. Microbiol. 40: 1376-1380 [Abstract] [Full Text]  
  • Ferraro, M. J., Swenson, J. M., Tenover, F. C. (2002). Detection of Staphylococci with Reduced Susceptibility to Glycopeptides. J. Clin. Microbiol. 40: 1573-1573 [Full Text]  
  • Ike, Y., Arakawa, Y., Ma, X., Tatewaki, K., Nagasawa, M., Tomita, H., Tanimoto, K., Fujimoto, S. (2001). Nationwide Survey Shows that Methicillin-Resistant Staphylococcus aureus Strains Heterogeneously and Intermediately Resistant to Vancomycin Are Not Disseminated throughout Japanese Hospitals. J. Clin. Microbiol. 39: 4445-4451 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»